Author Affiliations: Division of Cardiovascular Disease, University of Michigan Medical Center, Ann Arbor.
Technological developments in device therapy for both bradyarrhythmias
and tachyarrhythmias have benefited hundreds of thousands of patients over
the past several decades. By the end of 2000, more than 900 000 persons
in the United States had a pacemaker or implantable cardioverter-defibrillator
(ICD) generator.1 The benefits of modern-day
pacing and defibrillator therapy on both quality and quantity of life are
well documented.2- 4
Moreover, the recent receipt of an ICD by Vice President Richard Cheney has
resulted in increased public awareness about the use and capabilities of these
Eagle KA. Safety Alerts Involving Device Therapy for Arrhythmias. JAMA. 2001;286(7):843–844. doi:10.1001/jama.286.7.843
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.